跳至主要内容
临床试验/NCT02571179
NCT02571179已完成4 期

Intranasal Fentanyl in Treatment of Labour Pain - Efficacy and Safety

Kuopio University Hospital1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2011年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
Fentanyl maximum concentration

研究概览

简要总结

Physiological changes during pregnancy are known to affect the pharmacokinetics of many drugs. Intranasal fentanyl is an interesting option for obstetric analgesia, but its use in pregnant patients has not been established. The investigators studied pharmacokinetics of intranasal fentanyl in labouring women and to subsequently evaluate the maternal and fetal safety after administration.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • healthy parturients with uncomplicated, single gestation pregnancies, full term (38-42 weeks of gestation) pregnancy, agreed to participate

排除标准

  • a disease that might affect hepatic or renal function, contraindications to opioid analgesics, fetal growth retardation, signs of fetal asphyxia by cardiotocography, meconium stained amniotic fluid or placental insufficiency. The subjects should not have received fentanyl during the previous 14 days.
  • Not agreed to participate

研究组 & 干预措施

Intranasal fentanyl 50 microg/dose

Experimental

patient was given intranasal fentanyl 50 microg/dose up to 250 microg

干预措施: intranasal fentanyl 50 microg dose up to 250 microg (Drug)

结局指标

主要结局

Fentanyl maximum concentration

时间窗: From the first intranasal fentanyl dose to birth of the newborn up to 48 hours

次要结局

未报告次要终点

研究者

发起方
Kuopio University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Merja Kokki

MD, PhD

Kuopio University Hospital

研究点 (1)

Loading locations...

相似试验